{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:24:34Z","timestamp":1793053474317,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vision Tech Bio Pty Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-025-01373-y","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:15:33Z","timestamp":1768540533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Prospective, Cross-Sectional, Multicenter Study Evaluating a Multi-Target Blood Protein in Vitro Diagnostic Test for Colorectal Cancer"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8231-7735","authenticated-orcid":false,"given":"Emily Y.","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-7993","authenticated-orcid":false,"given":"Guy A.","family":"van Hazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Sloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-2140","authenticated-orcid":false,"given":"Stephen","family":"Pianko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9807-7537","authenticated-orcid":false,"given":"Gregor J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4766-9954","authenticated-orcid":false,"given":"Philip R.","family":"Clingan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-6054","authenticated-orcid":false,"given":"Rajvinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-0226","authenticated-orcid":false,"given":"Ann C.","family":"Solterbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Traficante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8063-071X","authenticated-orcid":false,"given":"Louise","family":"Formby-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4035-9678","authenticated-orcid":false,"given":"Trevor","family":"Lockett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finlay","family":"Macrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"1","key":"1373_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3748\/wjg.v24.i1.124","volume":"24","author":"F Benard","year":"2018","unstructured":"Benard F, Barkun AN, Martel M, von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 2018;24(1):124\u201338. https:\/\/doi.org\/10.3748\/wjg.v24.i1.124.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1373_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41575-022-00612-y","volume":"19","author":"A Shaukat","year":"2022","unstructured":"Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. 2022;19(8):521\u201331. https:\/\/doi.org\/10.1038\/s41575-022-00612-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"1373_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archinternmed.2012.332","volume":"172","author":"JM Inadomi","year":"2012","unstructured":"Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575\u201382. https:\/\/doi.org\/10.1001\/archinternmed.2012.332.","journal-title":"Arch Intern Med"},{"key":"1373_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.21037\/tgh.2019.12.13","volume":"4","author":"S Rosello","year":"2019","unstructured":"Rosello S, Simon S, Cervantes A. Programmed colorectal cancer screening decreases incidence and mortality. Transl Gastroenterol Hepatol. 2019;4:84. https:\/\/doi.org\/10.21037\/tgh.2019.12.13.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"19","key":"1373_CR5","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/jama.2021.4417","volume":"325","author":"JS Lin","year":"2021","unstructured":"Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA. 2021;325(19):1978\u201397. https:\/\/doi.org\/10.1001\/jama.2021.4417.","journal-title":"JAMA"},{"issue":"20","key":"1373_CR6","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3748\/wjg.v23.i20.3632","volume":"23","author":"M Navarro","year":"2017","unstructured":"Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017;23(20):3632\u201342. https:\/\/doi.org\/10.3748\/wjg.v23.i20.3632.","journal-title":"World J Gastroenterol"},{"key":"1373_CR7","doi-asserted-by":"publisher","first-page":"116022","DOI":"10.1016\/j.socscimed.2023.116022","volume":"329","author":"A Le Bonniec","year":"2023","unstructured":"Le Bonniec A, Meade O, Fredrix M, Morrissey E, O\u2019Carroll RE, Murphy PJ, et al. Exploring non-participation in colorectal cancer screening: A systematic review of qualitative studies. Soc Sci Med. 2023;329:116022. https:\/\/doi.org\/10.1016\/j.socscimed.2023.116022.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1373_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12529-021-09976-y","volume":"29","author":"A Le Bonniec","year":"2022","unstructured":"Le Bonniec A, Gourlan M, Pr\u00e9au M, Cousson-G\u00e9lie F. Action control of colorectal cancer screening participation with fecal immunochemical test (FIT). Int J Behav Med. 2022;29(1):122\u201330. https:\/\/doi.org\/10.1007\/s12529-021-09976-y.","journal-title":"Int J Behav Med"},{"key":"1373_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-230x-14-183","volume":"14","author":"A Adler","year":"2014","unstructured":"Adler A, Geiger S, Keil A, Bias H, Schatz P, deVos T, et al. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol. 2014;14:183. https:\/\/doi.org\/10.1186\/1471-230x-14-183.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1373_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/gutjnl-2023-330980","volume":"73","author":"GD Coronado","year":"2024","unstructured":"Coronado GD, Jenkins CL, Shuster E, Johnson C, Amy D, Cook J, et al. Blood-based colorectal cancer screening in an integrated health system: a randomised trial of patient adherence. Gut. 2024;73(4):622\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2023-330980.","journal-title":"Gut"},{"issue":"3","key":"1373_CR11","doi-asserted-by":"publisher","first-page":"e0120425","DOI":"10.1371\/journal.pone.0120425","volume":"10","author":"KY Fung","year":"2015","unstructured":"Fung KY, Tabor B, Buckley MJ, Priebe IK, Purins L, Pompeia C, et al. Blood-based protein biomarker panel for the detection of colorectal cancer. PLoS ONE. 2015;10(3):e0120425. https:\/\/doi.org\/10.1371\/journal.pone.0120425.","journal-title":"PLoS ONE"},{"key":"1373_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gut.47.2.251","volume":"47","author":"RJ Schlemper","year":"2000","unstructured":"Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of Gastrointestinal epithelial neoplasia. Gut. 2000;47:251\u20135.","journal-title":"Gut"},{"key":"1373_CR13","first-page":"003","volume":"S6","author":"KYC Fung","year":"2013","unstructured":"Fung KYC, Purins L, C P, Brierley GV, Tabor B, Lockett T, et al. Analysis of 32 Blood-Based protein biomarkers for their potential to diagnose colorectal cancer. J Mol Biomarkers Diagnosis. 2013;S6:003.","journal-title":"J Mol Biomarkers Diagnosis"},{"issue":"2","key":"1373_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0272989x8700700208","volume":"7","author":"DL Simel","year":"1987","unstructured":"Simel DL, Feussner JR, DeLong ER, Matchar DB. Intermediate, indeterminate, and uninterpretable diagnostic test results. Med Decis Making: Int J Soc Med Decis Mak. 1987;7(2):107\u201314. https:\/\/doi.org\/10.1177\/0272989x8700700208.","journal-title":"Med Decis Making: Int J Soc Med Decis Mak"},{"key":"1373_CR15","unstructured":"USDepartment of Health and Human Services, Medicare National Coverage Determinations Manual. Chap. 1, Part 4 (Sects.\u00a0200-310.1), Transmittal 210.3 - Screening for Colorectal Cancer (CRC) Blood-Based Biomarker Tests. 2024, pp 7-14. Cited 2025 June 06. Available from https:\/\/www.cms.gov\/regulations-and-guidance\/guidance\/manuals\/downloads\/ncd103c1_part4.pdf."},{"issue":"158","key":"1373_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","volume":"22","author":"EB Wilson","year":"1927","unstructured":"Wilson EB. Probable inference, the law of Succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209\u201312. https:\/\/doi.org\/10.1080\/01621459.1927.10502953.","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"1373_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.14309\/ajg.0000000000000465","volume":"115","author":"T Niedermaier","year":"2020","unstructured":"Niedermaier T, Balavarca Y, Brenner H. Stage-Specific sensitivity of fecal immunochemical tests for detecting colorectal cancer: systematic review and Meta-Analysis. Am J Gastroenterol. 2020;115(1):56\u201369. https:\/\/doi.org\/10.14309\/ajg.0000000000000465.","journal-title":"Am J Gastroenterol"},{"key":"1373_CR18","doi-asserted-by":"publisher","unstructured":"Switalski J, Tatara T, Wnuk K, Miazga W, Karauda D, Matera A, et al. Clinical effectiveness of faecal immunochemical test in the early detection of colorectal Cancer-An umbrella review. Cancers (Basel). 2022;14(18). https:\/\/doi.org\/10.3390\/cancers14184391.","DOI":"10.3390\/cancers14184391"},{"issue":"6378","key":"1373_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Sci (New York NY). 2018;359(6378):926\u201330. https:\/\/doi.org\/10.1126\/science.aar3247.","journal-title":"Sci (New York NY)"},{"key":"1373_CR20","doi-asserted-by":"publisher","first-page":"e2200679","DOI":"10.1200\/PO.22.00679","volume":"7","author":"AH Bryce","year":"2023","unstructured":"Bryce AH, Thiel DD, Seiden MV, Richards D, Luan Y, Coignet M, et al. Performance of a Cell-Free DNA-Based Multi-cancer detection test in individuals presenting with symptoms suspicious for cancers. JCO Precis Oncol. 2023;7:e2200679. https:\/\/doi.org\/10.1200\/PO.22.00679.","journal-title":"JCO Precis Oncol"},{"key":"1373_CR21","first-page":"131","volume":"26","author":"L Rabeneck","year":"2012","unstructured":"Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol Hepatol. 2012;26:131\u201347.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"1373_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-015-0826-7","volume":"16","author":"JJ You","year":"2015","unstructured":"You JJ, Liu Y, Kirby J, Vora P, Moayyedi P. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial. Trials. 2015;16(1):1\u20136.","journal-title":"Trials"},{"issue":"Suppl 3:Se","key":"1373_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-0032-1309791","volume":"44","author":"SP Halloran","year":"2012","unstructured":"Halloran SP, Launoy G, Zappa M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition\u2013Faecal occult blood testing. Endoscopy. 2012;44(Suppl 3:Se):65\u201387. https:\/\/doi.org\/10.1055\/s-0032-1309791.","journal-title":"Endoscopy"},{"issue":"2","key":"1373_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. Cancer J Clin. 2017;67(2):93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"Cancer J Clin"},{"issue":"1","key":"1373_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.gastro.2017.09.018","volume":"154","author":"A Gies","year":"2018","unstructured":"Gies A, Cuk K, Schrotz-King P, Brenner H. Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening. Gastroenterology. 2018;154(1):93\u2013104. https:\/\/doi.org\/10.1053\/j.gastro.2017.09.018.","journal-title":"Gastroenterology"},{"key":"1373_CR26","doi-asserted-by":"publisher","unstructured":"Chung DC, Gray DM 2nd, Singh H, Issaka RB, Raymond VM, Eagle C, et al. A Cell-free DNA Blood-Based test for colorectal cancer screening. N Engl J Med. 2024;390(11):973\u201383. https:\/\/doi.org\/10.1056\/NEJMoa2304714.","DOI":"10.1056\/NEJMoa2304714"},{"issue":"2","key":"1373_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/gutjnl-2012-304149","volume":"63","author":"TR Church","year":"2014","unstructured":"Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014;63(2):317\u201325. https:\/\/doi.org\/10.1136\/gutjnl-2012-304149.","journal-title":"Gut"},{"key":"1373_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12885-015-1674-2","volume":"15","author":"SK Pedersen","year":"2015","unstructured":"Pedersen SK, Symonds EL, Baker RT, Murray DH, McEvoy A, Van Doorn SC, et al. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer. 2015;15:654. https:\/\/doi.org\/10.1186\/s12885-015-1674-2.","journal-title":"BMC Cancer"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01373-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:15:37Z","timestamp":1768540537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01373-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01373-y","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"7 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional Human Research Ethics Committees and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the Central Adelaide Local Health Network Human Research Ethics Committee, Reference No HREC\/18\/CALHN\/534 and endorsed by the Human Research Ethics Committees of the participating study centres.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in this study. Bio-banked samples were obtained from participants who had taken part in an ethics-approved clinical trial conducted according to ICH GCP guidelines and provided informed consent, including for their samples to be used for future research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Financial: Authors Stephen Pianko and Finlay Macrae have received research funding from Rhythm Diagnostic Systems. Finlay Macrae has also received honoraria from Genetic Technologies Pty Ltd and Glutagen Pty Ltd. Rajvinder Singh has received consulting fees from Olympus (Australia) Pty Ltd and honoraria from Boston Scientific Pty Ltd and Olympus (Australia) Pty Ltd. Ann Solterbeck and Robert Traficante have received consulting fees from Rhythm Biosciences Limited. Louise Formby-Miller and Trevor Lockett are both former employees of Rhythm Biosciences Limited and have stock interests in the company. Trevor Lockett has is also a past member of the Rhythm Biosciences Board and is a consultant to the company. Non-Financial: Finlay Macrae is a Member of the Clinical Advisory Group to the Australian National Bowel Cancer Screening Program. Emily He, Guy van Hazel, Andrew Sloss and Philip Clingan have no relevant financial or non-financial interests to disclose.\u2003Emily He, Guy van Hazel, Andrew Sloss and Philip Clingan have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No material has been reproduced from other sources.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permissions"}}],"article-number":"19"}}